Autres langues SofWave Medical Ltd.

Actions

SOFW

IL0011754392

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 16:24:36 04/07/2024			Varia. 5j.	Varia. 1 janv.
1 735 ^ILa	-0,12 %		-0,86 %	+26,46 %

11/06	Sofwave Medical Ltd reçoit l'autorisation de mise en marché au Canada pour le dispositif de musculation Pure Impact ? appareil de musculation et de renforcement musculaire	CI
09/05	SofWave Medical Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sofwave Medical Receives Marketing Clearance in Canada for Pure Impact™ Strength and Muscle Toning Device	11/06
Sofwave Medical Ltd Receives Marketing Clearance in Canada for Pure Impact? Strength and Muscle Toning Device	11/06
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights	09/05
SofWave Medical : Presentation- Q1 2024 Summary-May 2024	09/05
SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	28/03
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	06/03
SofWave Medical : Presentation- Investor Meeting-March 2024	06/03
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	04/03
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	28/02
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	12/02
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer	12/02
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	03/01
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	03/01
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	20/11
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	08/11
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SofWave Medical Ltd.

Actions

SOFW

IL0011754392

Autres langues

Filtres